Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
INVA

INVA - Innoviva Inc Stock Price, Fair Value and News

16.22USD+0.06 (+0.37%)Market Closed

Market Summary

INVA
USD16.22+0.06
Market Closed
0.37%

INVA Stock Price

View Fullscreen

INVA RSI Chart

INVA Valuation

Market Cap

1.0B

Price/Earnings (Trailing)

10.13

Price/Sales (Trailing)

3.25

EV/EBITDA

5.86

Price/Free Cashflow

6.66

INVA Price/Sales (Trailing)

INVA Profitability

EBT Margin

63.57%

Return on Equity

14.21%

Return on Assets

7.89%

Free Cashflow Yield

15.01%

INVA Fundamentals

INVA Revenue

Revenue (TTM)

311.6M

Rev. Growth (Yr)

1.48%

Rev. Growth (Qtr)

-9.72%

INVA Earnings

Earnings (TTM)

100.0M

Earnings Growth (Yr)

4.78%

Earnings Growth (Qtr)

284.07%

Breaking Down INVA Revenue

Last 7 days

2.0%

Last 30 days

1.5%

Last 90 days

9.7%

Trailing 12 Months

24.2%

How does INVA drawdown profile look like?

INVA Financial Health

Current Ratio

10.42

Debt/Equity

0.63

Debt/Cashflow

0.34

INVA Investor Care

Buy Backs (1Y)

4.67%

Diluted EPS (TTM)

2.23

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024311.6M000
2023310.9M290.4M290.4M310.5M
2022376.7M361.6M346.5M331.3M
2021350.6M364.3M378.1M391.9M
2020284.5M299.4M322.3M336.8M
2019263.8M260.8M264.9M261.0M
2018229.1M237.6M250.7M261.0M
2017149.9M176.0M191.3M217.2M
201671.2M93.0M112.8M133.6M
201516.1M25.8M38.4M53.9M
20145.5M6.5M7.5M8.4M
20135.3M5.1M4.8M4.5M
2012145.3M140.3M135.3M5.6M
201124.3M24.4M24.4M24.5M
201000024.2M
200900024.4M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Innoviva Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 20, 2024
ronsheim matthew
sold (taxes)
-4,322
16.13
-268
see remarks
May 20, 2024
zhen marianne
sold (taxes)
-15,742
16.13
-976
chief accounting officer
Mar 05, 2024
ronsheim matthew
acquired
189,988
14.88
12,768
see remarks
Mar 05, 2024
basso stephen
acquired
179,988
14.88
12,096
chief financial officer
Mar 05, 2024
zhen marianne
acquired
159,990
14.88
10,752
chief accounting officer
Feb 20, 2024
ronsheim matthew
sold (taxes)
-12,750
15.8
-807
see remarks
Feb 20, 2024
zhen marianne
sold (taxes)
-45,219
15.8
-2,862
chief accounting officer
Jan 18, 2024
ronsheim matthew
sold (taxes)
-25,680
16.05
-1,600
see remarks
Nov 20, 2023
zhen marianne
sold (taxes)
-10,678
13.62
-784
chief accounting officer
Nov 15, 2023
zhen marianne
sold
-153,810
13.9903
-10,994
chief accounting officer

1–10 of 50

Which funds bought or sold INVA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
unchanged
-
-534
8,673
-%
May 28, 2024
Boston Partners
added
90.33
2,666,630
5,965,890
0.01%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
-18,000
331,000
-%
May 21, 2024
China Universal Asset Management Co., Ltd.
added
64.26
66,501
185,501
0.02%
May 20, 2024
EMC Capital Management
sold off
-100
-459,000
-
-%
May 20, 2024
Pacific Center for Financial Services
unchanged
-
-160
3,048
-%
May 16, 2024
COMERICA BANK
reduced
-29.6
-1,388,920
2,806,320
0.01%
May 16, 2024
Redwood Investment Management, LLC
added
6.44
36,000
3,254,000
0.31%
May 16, 2024
Virtus Investment Advisers, Inc.
reduced
-43.13
-239,326
281,300
0.20%
May 16, 2024
Ancora Advisors LLC
new
-
3,673
3,673
-%

1–10 of 41

Are Funds Buying or Selling INVA?

Are funds buying INVA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own INVA
No. of Funds

Unveiling Innoviva Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
May 13, 2024
franklin resources inc
10.2%
6,412,700
SC 13G
May 08, 2024
franklin resources inc
10.2%
6,412,700
SC 13D
Feb 14, 2024
putnam investments llc
9.8%
6,270,413
SC 13G/A
Feb 13, 2024
renaissance technologies llc
6.47%
4,144,447
SC 13G/A
Feb 13, 2024
vanguard group inc
10.47%
6,712,443
SC 13G/A
Feb 09, 2024
dimensional fund advisors lp
7.0%
4,516,999
SC 13G
Jan 22, 2024
blackrock inc.
16.1%
10,349,116
SC 13G/A
May 15, 2023
sarissa capital management lp
10.54%
6,904,000
SC 13D/A
Feb 14, 2023
putnam investments llc
7.6%
5,329,107
SC 13G
Feb 13, 2023
renaissance technologies llc
6.06%
4,229,607
SC 13G/A

Recent SEC filings of Innoviva Inc

View All Filings
Date Filed Form Type Document
May 21, 2024
4
Insider Trading
May 21, 2024
4
Insider Trading
May 13, 2024
SC 13G
Major Ownership Report
May 13, 2024
8-K
Current Report
May 09, 2024
ARS
ARS
May 08, 2024
SC 13D
13D - Major Acquisition
May 08, 2024
8-K
Current Report
May 08, 2024
10-Q
Quarterly Report
May 01, 2024
3
Insider Trading
Apr 30, 2024
8-K
Current Report

Peers (Alternatives to Innoviva Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
51.1B
6.8B
0.28% 3.53%
-8.56
7.46
-64.45% -224.75%
22.5B
216.3K
-0.77% 465779.94%
-2.5K
104.0K
- -8.13%
19.5B
2.0B
2.99% -23.67%
-58.61
9.71
75.20% 68.82%
16.0B
2.5B
8.50% -12.61%
77.77
6.46
13.74% 186.89%
13.8B
3.8B
7.60% -2.83%
18.51
3.66
8.58% 129.81%
MID-CAP
5.2B
107.9M
-8.24% 83.94%
-9.45
48.09
54.84% -28.31%
4.9B
524.1M
-2.95% -55.09%
-11.66
9.28
394.93% 39.61%
3.6B
251.0M
-0.68% -10.56%
-12.18
14.38
73.58% -86.73%
2.9B
240.7M
-4.80% -33.39%
-6.19
12.77
-1.03% -213.92%
2.5B
813.8M
0.54% -38.22%
-1.4K
3.02
56.43% 98.83%
1.9B
996.6M
5.92% 71.39%
-4.85
1.94
-26.66% 65.49%
SMALL-CAP
1.8B
411.3M
-9.22% 22.70%
27.15
4.3
60.38% -34.49%
468.2M
881.7K
-2.64% 488.84%
-13.87
481.06
-77.61% 33.36%
221.8M
4.2M
-28.67% 45.58%
-1.78
53.32
-66.30% 48.24%
19.9M
2.1M
16.67% 230.00%
-0.86
7.61
-13.45% 69.54%

Innoviva Inc News

Latest updates
Defense World3 hours ago
Defense World17 Jun 202411:50 am
Yahoo New Zealand News16 Jun 202402:00 am
Yahoo New Zealand News15 Jun 202412:28 am
Yahoo Movies Canada03 Jun 202411:26 am

Innoviva Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-9.7%77.0086.0067.0081.0076.0066.0067.0081.0094.0010898.0095.0093.0090.0089.0079.0079.0076.0066.0064.0055.00
Costs and Expenses31.4%32.0025.00-18.6975.0035.00130-21988.0045.00------------
Operating Expenses--------21926.0012.0077.00-25.314.006.006.004.003.003.002.005.004.003.00
  S&GA Expenses15.5%30.0026.0029.0024.0020.0017.0028.0012.006.003.003.004.006.005.003.003.003.002.005.004.003.00
  R&D Expenses64.6%4.002.004.0015.0013.0010.0012.0014.006.000.000.000.000.000.001.001.00-----
EBITDA Margin2.2%0.70*0.69*0.32*0.94*0.97*0.96*1.27*0.76*1.04*1.22*1.35*1.21*---------
Interest Expenses-1.7%6.006.004.004.004.004.005.004.003.005.005.005.005.005.005.005.005.005.005.005.005.00
Income Taxes2730.0%9.00-0.334.005.006.004.0057.00-0.887.0011.0021.0025.0020.0016.009.0020.0016.0012.0011.0010.009.00
Earnings Before Taxes-26.3%45.0061.0086.006.0041.00-64.6928620.0045.0056.0012313612991.0050.0011895.0070.0058.0056.0049.00
EBT Margin1.7%0.64*0.63*0.22*0.84*0.87*0.87*1.18*0.68*0.96*1.14*1.27*1.12*---------
Net Income284.1%37.00-19.8582.001.0035.00-10.3122921.0038.00-6.05103111110-6.6242.0098.0079.0058.0047.0046.0040.00
Net Income Margin1.3%0.32*0.32*0.34*0.80*0.84*0.84*-0.09*0.88*0.84*0.81*0.84*0.70*---------
Free Cashflow11.9%37.0033.0044.0038.0026.009.0016.0079.0098.0098.0097.0085.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets1.9%1,2681,2441,1881,1181,1301,2311,3281,1381,1079268877891,0881,000922880788725676642590
  Current Assets-9.6%31134430532429644433.0040031831450.0014837334268.00500467431367318252
    Cash Equivalents-7.8%17819418017314429130128421720213543.0028324647941335227817314265.00
  Inventory-8.1%37.0041.0041.0047.0050.0056.0071.00--------------
  Net PPE-32.9%0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
  Goodwill0%18.0018.0018.0015.0028.0027.0016.0012.006.00------------
  Current Liabilities-21.6%30.0038.0036.0039.0038.001357.001261096.005.005.004.006.007.005.003.005.003.007.004.00
  Long Term Debt0.1%447446446445445444444443443395392390388386383381379377389387385
    LT Debt, Current------96.0096.0096.0096.00------------
    LT Debt, Non Current0.1%447446446445445444444443443395392390388386383381379377389387385
Shareholder's Equity4.3%704675627555561566641565552526492394697608535493406342284247200
  Retained Earnings145.0%11.00-25.19-86.72-168-170-204-136-402-403-456-466-538-627-722-775-804-880-946-992-1,032-1,069
  Additional Paid-In Capital-0.7%1,0861,0931,1071,1171,1251,1641,1711,1841,1831,2641,2621,2621,2611,2611,2601,2601,2591,2591,2581,2581,257
Shares Outstanding-0.8%63.0063.0064.0065.0068.0069.0070.0070.0070.0082.0069.0088.00---------
Minority Interest--------17716611189.0064.0062.0068.0049.0036.0026.0029.0017.0020.0012.00
Float----731,927---924---840,847---877---1,006-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations11.4%37,04733,25643,94238,18225,6848,89915,69079,03598,10298,38196,71184,61484,10785,28074,55879,79473,48166,90557,40256,49676,655
  Share Based Compensation13.9%1,4551,2771,4421,5201,5981,3263,7171,350954554542470451447441375435488489474605
Cashflow From Investing-735.5%-43,038-5,151-25,888--35,722-8,67897,722-2,522-143,156-19,905-90,021-26,394-315,481-8,500-7,00016,04451,994-15,93720,107-74,167
Cashflow From Financing37.2%-9,165-14,589-11,082-9,206-136,962-10,001-96,163-9,73560,331-12,066-4,861-414,260-21,310-2,505-12.00-11,628-15,640-13,749-10,471198246
  Dividend Payments--------------------3.008.00
  Buy Backs-34.6%9,56914,63611,0719,28640,7358,503---------------
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

INVA Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:  
Total revenue$ 77,499$ 76,372
Expenses:  
Selling, general and administrative30,40519,735
Research and development3,87812,588
Amortization of acquired intangible assets6,4403,805
Changes in fair values of equity method investments, net(35,342)(15,817)
Changes in fair values of equity and long-term investments, net13,3352,164
Interest and dividend income(4,399)(3,365)
Interest expense5,8514,427
Other expense, net1,2361,346
Total expenses, net32,37535,232
Income before income taxes45,12441,140
Income tax expense, net8,5926,275
Net income and comprehensive income$ 36,532$ 34,865
Net income per share:  
Basic$ 0.58$ 0.51
Diluted$ 0.46$ 0.42
Shares used to compute net income per share:  
Basic63,18567,786
Diluted84,53189,788
Royalty revenue  
Revenue:  
Total revenue$ 58,415$ 56,858
Net product sales  
Revenue:  
Total revenue19,08411,514
Expenses:  
Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding amortization of intangible assets)10,9718,749
License revenue  
Revenue:  
Total revenue08,000
License  
Expenses:  
Cost of license revenue$ 0$ 1,600

INVA Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:  
Cash and cash equivalents$ 178,357$ 193,513
Accounts receivable14,13914,454
Receivables from collaboration arrangement61,87169,621
Inventory37,43740,737
Prepaid expenses16,55121,630
Other current assets2,9874,264
Total current assets311,342344,219
Property and equipment, net324483
Equity method investments151,888116,546
Equity and long-term investments476,549444,432
Capitalized fees paid, net80,32883,784
Right-of-use assets2,2692,536
Goodwill17,90517,905
Intangible assets223,895230,335
Other assets3,1123,267
Total assets1,267,6121,243,507
Current liabilities:  
Accounts payable8906,717
Accrued personnel-related expenses3,4227,020
Accrued interest payable8333,422
Deferred revenue9871,277
Other accrued liabilities23,74719,698
Total current liabilities29,87938,134
Long-term debt, net of discount and issuance costs446,759446,234
Other long-term liabilities71,68671,870
Deferred tax liabilities, net3,807563
Income tax payable, long-term11,80011,751
Commitments and contingencies (Note 12)
Stockholders' equity:  
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding00
Common stock: $0.01 par value, 200,000 shares authorized, 62,797 and 63,307 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively628633
Treasury stock: at cost, 32,005 shares as of March 31, 2024 and December 31, 2023(393,829)(393,829)
Additional paid-in capital1,085,5391,093,340
Retained earnings (accumulated deficit)11,343(25,189)
Total stockholders' equity703,681674,955
Total liabilities and stockholders' equity$ 1,267,612$ 1,243,507
INVA
Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA) and umeclidinium bromide (UMEC) with a LABA, VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. It has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
 WEBSITEinva.com
 INDUSTRYBiotechnology
 EMPLOYEES101

Innoviva Inc Frequently Asked Questions


What is the ticker symbol for Innoviva Inc? What does INVA stand for in stocks?

INVA is the stock ticker symbol of Innoviva Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Innoviva Inc (INVA)?

As of Tue Jun 18 2024, market cap of Innoviva Inc is 1.01 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INVA stock?

You can check INVA's fair value in chart for subscribers.

What is the fair value of INVA stock?

You can check INVA's fair value in chart for subscribers. The fair value of Innoviva Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Innoviva Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for INVA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Innoviva Inc a good stock to buy?

The fair value guage provides a quick view whether INVA is over valued or under valued. Whether Innoviva Inc is cheap or expensive depends on the assumptions which impact Innoviva Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INVA.

What is Innoviva Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Jun 18 2024, INVA's PE ratio (Price to Earnings) is 10.13 and Price to Sales (PS) ratio is 3.25. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INVA PE ratio will change depending on the future growth rate expectations of investors.